Skip to content

the significance of biomarkers in abdominal drain fluid for anastomotic leakage.

Predictive value of perianastomotic drain fluid biomarkers in anastomotic leak: a cohort study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069141
Enrollment
110
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K639- Disease of intestine, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

AIIMS NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 18 – 70 Years 2. Both gender 3. Post-operative abdominal surgery undergone intestinal anastomosis 4. Patients can follow instructions and are ready for regular follow up 5. Able to provide informed and written consent 6. Non-trauma elective and emergency cases with small intestine perforation or obstruction. 7. Mesenteric ischemia or strangulation: Small Intestinal obstruction with segmental ischemia or gangrene 8. Tumour: small bowel mass , Small bowel malignancy with adequate negative margin 9. Entero-cutaneous fistula 10. Symptomatic benign disease such as Meckles diverticulum or perforated diverticulitis or intussusception of bowel needing resection and anastomosis 11. Incarcerated hernia 12. Patients with ileostomy for closure

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years and more than 70 years 2. Patients taking immunosuppressive therapy and chemotherapy. 3. Patients with known hematological disorders or malignancy. 4. Patients with known chronic liver or kidney disease 5. Auto-immune disease or immunodeficiency syndrome 6. Pregnant or lactating mother 7. Refusal to consent or participate in the study 8. Proximal diverting ostomy creation at the time of intestinal anastomosis 9. Patients receiving Albumin Supplementation during the period of the study. 10. Abdominal trauma with small intestine perforation or obstruction. 11. Active inflammatory bowel disease (Crohn’s enteritis with complications) 12. Anastomosis involving oesophagus, stomach, duodenum, colon and rectum 13. Patients on immunosuppressive drugs, post-chemotherapy or post-radiotherapy

Design outcomes

Primary

MeasureTime frame
1. Diagnostic accuracy of drain fluid biomarkers in predicting anastomotic leakTimepoint: 5 days

Secondary

MeasureTime frame
1. Duration of ICU & hospital stay 2. Post-operative morbidity: Clavien- Dindo classification 3. Post-op complications: SSI, IA abscess, obstruction, Burst abdomen, AKI, LRTI, ARDS, DVT 4. Post-operative re-intervention 5. Quality of life 6. Cost-analysis 7. Mortality Timepoint: 1. Days 2. Clavien Dindo classification 3. Yes or No 4. Days 5. questionnaire 6. In rupees 7. Yes or No

Countries

India

Contacts

Public ContactDr Sweta Bhartiya

All India Institute of Medical Sciences New Delhi

sweta.bhartiya96@gmail.com9996552211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026